Latest reported quarter: Q2, ended Jun 2026 · reported in ARS
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 ANNUAL (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
|---|---|---|---|---|---|
| Total Operating Revenue | ARS 1.21T | ARS 1.18T | ARS 3.05T | ARS 584.56B | ARS 846.37B |
| Net Interest Income | ARS 929.56B | ARS 898.40B | ARS 2.79T | ARS 927.66B | ARS 601.98B |
| -Interest Income | ARS 1.47T | ARS 1.55T | ARS 5.37T | ARS 1.87T | ARS 1.33T |
| -Interest Expense | ARS 536.48B | ARS 650.24B | ARS 2.58T | ARS 939.55B | ARS 727.57B |
| Non-Interest Income | ARS 276.95B | ARS 283.37B | ARS 261.23B | -ARS 343.10B | ARS 244.39B |
| -Fees and Commissions | ARS 201.11B | ARS 192.38B | ARS 588.37B | ARS 192.21B | ARS 153.84B |
| -Foreign Exchange Trading Gains | ARS 48.56B | ARS 53.33B | ARS 193.09B | ARS 65.84B | ARS 60.65B |
| -Other Non-Interest Income | ARS 18.32B | ARS 19.13B | ARS 51.61B | ARS 6.14B | ARS 30.03B |
| -Gain Loss on Sale of Assets | ARS 8.96B | ARS 18.53B | -ARS 571.83B | -ARS 607.29B | -ARS 134.51M |
| Credit Losses Provision | -ARS 298.62B | -ARS 241.13B | ARS 33.03B | ARS 489.96B | -ARS 203.02B |
| Non-Interest Expense | ARS 567.82B | ARS 586.33B | ARS 2.02T | ARS 611.23B | ARS 470.84B |
| Selling and Admin Expenses | ARS 340.48B | ARS 339.19B | ARS 1.19T | ARS 334.58B | ARS 277.37B |
| -Selling & Marketing Expense | ARS 7.88B | ARS 11.73B | ARS 50.89B | ARS 13.04B | ARS 10.07B |
| -General & Admin Expense | ARS 332.60B | ARS 327.46B | ARS 1.14T | ARS 321.55B | ARS 267.30B |
| Depreciation & Amortization & Depletion | ARS 36.75B | ARS 32.09B | ARS 111.10B | ARS 37.98B | ARS 24.78B |
| -Depreciation & Amortization | ARS 36.75B | ARS 32.09B | ARS 111.10B | ARS 37.98B | ARS 24.78B |
| Other Non-Interest Expenses | ARS 190.59B | ARS 215.05B | ARS 717.02B | ARS 238.67B | ARS 168.68B |
| Other Income (Expense) | -ARS 158.22B | -ARS 222.35B | -ARS 550.27B | -ARS 248.16B | -ARS 111.16B |
| Income from Associates & Other Participating Interests | ARS 318.73M | -ARS 3.75B | ARS 11.95B | ARS 3.64B | ARS 3.21B |
| Special Income (Charges) | -ARS 158.54B | -ARS 218.59B | -ARS 562.23B | -ARS 251.79B | -ARS 114.37B |
| -Less:Other Special Charges | ARS 176.69B | ARS 218.59B | ARS 571.21B | ARS 174.48B | ARS 110.95B |
| -Less:Write Off | -ARS 18.16B | – | – | – | ARS 3.43B |
| Pretax Profit | ARS 181.85B | ARS 131.98B | ARS 519.82B | ARS 215.13B | ARS 61.35B |
| Tax | ARS 50.29B | ARS 46.75B | ARS 187.25B | ARS 75.48B | ARS 23.28B |
| Net Profit | ARS 131.56B | ARS 85.22B | ARS 332.57B | ARS 139.65B | ARS 38.07B |
| Profit from Continuing Operations | ARS 131.56B | ARS 85.22B | ARS 332.57B | ARS 139.65B | ARS 38.07B |
| Minority Interests | ARS 4.94B | ARS 6.80B | ARS 17.43B | ARS 6.36B | ARS 2.99B |
| Net Income to Parent Company | ARS 126.62B | ARS 78.42B | ARS 315.14B | ARS 133.29B | ARS 35.09B |
| Net Income to Common Stockholders | ARS 126.62B | ARS 78.42B | ARS 315.14B | ARS 133.29B | ARS 35.09B |
| Basic EPS | ARS 619.97 | ARS 383.97 | ARS 1,543.03 | ARS 264.00 | ARS 171.79 |
| Diluted EPS | ARS 619.97 | ARS 383.97 | ARS 1,543.03 | ARS 264.00 | ARS 171.79 |
| Dividend Per Share | ARS 173.91 | ARS 149.89 | ARS 216.31 | ARS 140.55 | ARS 45.86 |
| -Less:Restructuring and Mergern & Acquisition | – | – | ARS 775.16M | – | – |
| -Less:Impairment of Capital Assets | – | – | -ARS 9.75B | – | – |
| Line item | 2026 Q2 (ARS) |
2026 Q1 (ARS) |
2025 Q4 (ARS) |
2025 Q3 (ARS) |
2025 Q2 (ARS) |
|---|---|---|---|---|---|
| Total Assets | ARS 28.14T | ARS 25.71T | ARS 25.41T | ARS 22.17T | ARS 19.26T |
| Cash, Cash Equivalents & Federal Funds Sold | ARS 4.08T | ARS 4.01T | ARS 4.75T | ARS 3.83T | ARS 3.31T |
| -Cash and Cash Equivalents | ARS 4.05T | ARS 4.01T | ARS 4.75T | ARS 3.83T | ARS 3.31T |
| -Money Market Investments | ARS 25.99B | – | – | – | – |
| Securities Investment | ARS 5.37T | ARS 4.07T | ARS 2.80T | ARS 3.13T | ARS 3.06T |
| -Available for Sale Securities | ARS 5.35T | ARS 4.05T | ARS 2.80T | ARS 3.12T | ARS 3.06T |
| -Short Term Investments | ARS 16.26B | ARS 11.07B | – | ARS 9.17B | ARS 8.94B |
| Long Term Equity Investment | ARS 49.04B | ARS 43.08B | ARS 38.57B | ARS 35.40B | ARS 31.82B |
| Derivative Assets | ARS 7.97B | ARS 72.45B | ARS 38.87B | ARS 57.69B | ARS 12.04B |
| Net Loan | ARS 16.35T | ARS 15.02T | ARS 14.41T | ARS 12.53T | ARS 11.12T |
| -Gross Loan | ARS 17.20T | ARS 15.82T | ARS 15.03T | ARS 12.96T | ARS 11.43T |
| -Allowance for Loans and Lease Losses | ARS 853.31B | ARS 798.27B | ARS 617.15B | ARS 431.94B | ARS 305.41B |
| Receivables | ARS 50.18B | ARS 242.11B | ARS 192.74B | ARS 268.97B | ARS 224.71B |
| -Other Receivables | ARS 50.18B | ARS 242.11B | ARS 192.74B | ARS 268.97B | ARS 224.71B |
| Net PPE | ARS 1.03T | ARS 970.04B | ARS 896.65B | ARS 814.27B | ARS 748.33B |
| -Gross PPE | ARS 1.03T | ARS 970.04B | ARS 1.27T | ARS 814.27B | ARS 748.33B |
| Goodwill and Other Intangible Assets | ARS 159.23B | ARS 137.81B | ARS 119.34B | ARS 101.96B | ARS 88.50B |
| -Other Intangible Assets | ARS 159.23B | ARS 137.81B | ARS 119.34B | ARS 101.96B | ARS 88.50B |
| Prepaid Assets | ARS 81.66B | ARS 117.66B | ARS 113.92B | ARS 95.20B | ARS 82.98B |
| Foreclosed Assets | ARS 244.30M | ARS 229.74M | ARS 210.76M | ARS 196.18M | ARS 185.87M |
| Deferred Assets | ARS 28.05B | ARS 91.01B | ARS 66.04B | ARS 117.01B | ARS 34.72B |
| Assets Held for Sale | ARS 1.75B | ARS 1.64B | ARS 3.24B | ARS 3.85B | ARS 3.64B |
| Other Assets | ARS 944.03B | ARS 943.63B | ARS 1.98T | ARS 1.19T | ARS 536.24B |
| Total Liabilities | ARS 23.81T | ARS 21.69T | ARS 21.87T | ARS 19.18T | ARS 16.33T |
| Total Deposits | ARS 19.21T | ARS 17.46T | ARS 17.21T | ARS 15.36T | ARS 13.03T |
| Derivative Product Liabilities | ARS 6.67B | ARS 13.99B | ARS 6.50B | ARS 74.16B | ARS 15.05B |
| Short-Term Debt and Capital Lease Obligation | ARS 8.55B | ARS 5.28B | ARS 3.38B | ARS 2.82B | ARS 2.40B |
| -Current Capital Lease Obligation | ARS 8.55B | ARS 5.28B | ARS 3.38B | ARS 2.82B | ARS 2.40B |
| Trading Liabilities | ARS 73.66B | ARS 35.12B | – | – | ARS 422.63M |
| Payables | ARS 543.37B | ARS 582.60B | ARS 638.23B | ARS 465.71B | ARS 456.54B |
| -Accounts Payable | ARS 209.48M | ARS 196.07M | ARS 188.53M | ARS 203.96M | ARS 190.99M |
| -Total Tax Payable | ARS 168.60B | ARS 308.94B | ARS 311.66B | ARS 108.69B | ARS 84.38B |
| -Dividends Payable | ARS 48.17B | ARS 0.00 | ARS 11.80B | ARS 21.88B | ARS 30.98B |
| -Other Payable | ARS 326.39B | ARS 273.46B | ARS 314.58B | ARS 334.93B | ARS 340.99B |
| Long Term Debt and Capital Lease Obligation | ARS 1.48T | ARS 1.29T | ARS 1.49T | ARS 985.95B | ARS 834.55B |
| -Long Term Debt | ARS 1.43T | ARS 1.24T | ARS 1.44T | ARS 943.35B | ARS 799.33B |
| -Long Term Capital Lease Obligation | ARS 46.58B | ARS 46.82B | ARS 48.12B | ARS 42.59B | ARS 35.22B |
| Non-Current Liabilities | ARS 52.86B | ARS 51.57B | ARS 50.31B | ARS 50.46B | ARS 61.93B |
| Employee Benefits | ARS 158.73B | ARS 127.13B | ARS 152.73B | ARS 159.89B | ARS 129.14B |
| Non-Current Deferred Liabilities | ARS 69.71B | ARS 74.51B | ARS 98.75B | ARS 82.85B | ARS 71.39B |
| Other Liabilities | ARS 2.21T | ARS 1.98T | ARS 1.75T | ARS 1.70T | ARS 1.73T |
| Total Equity | ARS 4.33T | ARS 4.02T | ARS 3.54T | ARS 2.98T | ARS 2.94T |
| Stockholders' Equity | ARS 4.19T | ARS 3.90T | ARS 3.43T | ARS 2.92T | ARS 2.88T |
| Capital Stock | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M |
| -Common Stock | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M | ARS 612.71M |
| Retained Earnings | ARS 210.35B | ARS 352.02B | ARS 2.24T | ARS 181.86B | ARS 138.50B |
| Gains/Losses Not Affecting Retained Earnings | ARS 2.58T | ARS 2.23T | -ARS 7.41B | ARS 1.63T | ARS 1.69T |
| Other Equity Interests | ARS 1.40T | ARS 1.31T | ARS 1.19T | ARS 1.11T | ARS 1.05T |
| Minority Interests | ARS 138.73B | ARS 128.41B | ARS 111.08B | ARS 62.38B | ARS 56.05B |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | – | ARS 66.90B | ARS 468.23B | ARS 300.57B | – |
| -Accumulated Depreciation | – | – | -ARS 373.19B | – | – |
| Additional Paid-In Capital | – | – | ARS 6.74B | – | – |
No comments yet — be the first to weigh in on BBAR.